Skip to main content
Log in

Efficacy of Amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to Chloroquine and Sulphadoxine/Pyrimethamine

  • Original Paper
  • Published:
Parasitology Research Aims and scope Submit manuscript

Abstract

Falciparum Malaria is hyperendemic in southern Nigeria and chloroquine resistance is an increasing problem. Therefore, the parasitological and haematological response to treatment with amodiaquine was studied in children under 5 years during a 14-day follow-up. Of 105 children who accomplished the study (out of 114 who were enrolled), 95.3% were parasite-negative on thick blood film on day 7, which decreased to 89.5% on day 14. The haemoglobin levels increased on average by 1.3% on day 14 (±1.9) and more pronounced in children with anaemia < 10 g/dl on enrolment. The number of patients with adverse events (mainly pruritus and nausea) was few. This study shows that amodiaquine is effective, safe and affordable in an area with high resistance to chloroquine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Antia-Obong OE, Alaribe AA, Young MU, Bassy A, Etim BV (1997) Chloroquine-resistant Plasmodium falciparum malaria among children in Calabar, south eastern Nigeria. Trop Doctor 27:146–149

    CAS  Google Scholar 

  • Brasseur P, Guiguemde R, Diallo S, Guiyedi V, Kombila M, Ringwald P, Olliario P (1999) Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa. Trans R Trop Med Hyg 93:645–650

    CAS  Google Scholar 

  • Ekvall H, Premji Z, Björkmann A (1998) Chloroquine treatment for uncomplicated malaria in an area with drug resistance: early treatment failure aggravates anaemia. Trans R Trop Med Hyg 92:556–560

    CAS  Google Scholar 

  • Ezedinachi E (1996) In vivo efficacy of chloroquine, halofantrine, pyrimethamine- sulphadoxine and qinghaosu in the treatment of malaria in Calabar, Nigeria. Central Afric J Med 42:109–111

    CAS  Google Scholar 

  • Falade CO, Salako LA, Sowunmi A, Oduola AMJ, Larcier P (1997) Comparative efficacy of halofantrine, chloroquine and sulphadoxine- pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans R Trop Med Hyg 91:58–62

    CAS  Google Scholar 

  • Guiyedi V, Koko J, Bouyou AM, Mabika MM, Matsiegui PB, Traore B, Kombila M (2001) Evaluation of efficacy and tolerance of amodiaquine versus chloroquine in the treatment of uncomplicated malaria outbreak in children of Gabon. Bull Soc Path Exot 94:253–257

    CAS  Google Scholar 

  • Hawley SR, Bray PG, Park BK, Ward SA (1996) Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine. Mol Biochem Parasitol 80:15–25

    CAS  PubMed  Google Scholar 

  • Oliario P, Nevill C, LeBras J, Ringwald P, Mussano P, Garner P, Brasseur P (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348:1196–1201

    PubMed  Google Scholar 

  • Oyegun CU (1999) Climate, relief and drainge. In: Alagoa EJ (ed) The land and people of Bayelsa state. Onyoma research publications, pp 31–44

  • Pradines B, Tall A, Parzy D, Spiegel A, Fu T, Hienne R, Trape JF, Doury JC (1998) In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. J Antimicrob Chem 42:333–339

    CAS  Google Scholar 

  • Ringwald P, Bickii J, Basco LK (1998) Amodiaquine as the first line treatment of malaria in Yaounde, Cameroon. Trans R Trop Med Hyg 92:212–213

    CAS  Google Scholar 

  • Shretta R, Omumbo J, Rapuoda B, Snow RW (2000) Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health 11:755–764

    Article  Google Scholar 

  • Sowunmi A, Salako LA (1992) Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria. Ann Trop Med Parasitol 86:1–8

    CAS  Google Scholar 

  • Sudre P, Breman JG, McFarland D, Koplan JP (1992) Treatment of Chloroquine-resistant malaria in african children: a cost-effectiveness analysis. Int J Epidemiol 21:146–154

    CAS  PubMed  Google Scholar 

  • Trape JF (2001) The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 64:1–25

    Google Scholar 

  • Van Dillen J, Custers M, Wensink A, Wouters van Voorhuizen T, Voorn W, Khan B (1999) comparison of amodiaquine and sulphadoxine–pyrimethamine as first line treatment of falciparum malaria in Kenya. Trans R Trop Med Hyg 93:185–188

    Article  Google Scholar 

  • WHO (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission WHO/96:1077

Download references

Acknowledgements

The results presented in this paper are part of a medical thesis by Jens Graupner

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus Göbels.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graupner, J., Göbels, K., Grobusch, M.P. et al. Efficacy of Amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to Chloroquine and Sulphadoxine/Pyrimethamine. Parasitol Res 96, 162–165 (2005). https://doi.org/10.1007/s00436-005-1325-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00436-005-1325-7

Keywords

Navigation